Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
01 Quantum Inc
DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering
Exascale Labs Holdings Inc. - Class A Common Stock
INNIO N.V. - Ordinary Shares
Maui Land & Pineapple Company, Inc. Common Stock
Medical Care Technologies Inc
Mercari Inc
Mitsui O.S.K. Lines ADR
Paladin Energy Ltd
Peer To Peer Network
Pirate Gold Corp
Scorpius Holdings, Inc. Common Stock
Silicon Laboratories, Inc. - Common Stock
Solstice Advanced Materials Inc. - Common Stock
Spectaire Holdings, Inc. - Warrants
Traction Uranium Corp
Trinity Biotech plc - American Depositary Shares
Vencanna Ventures Inc.
ViacomCBS Inc. - Class A Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Marker Therapeutics, Inc. - Common Stock
(NQ:
MRKR
)
1.040
+0.120 (+13.04%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Marker Therapeutics, Inc. - Common Stock
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11
December 11, 2023
Via
Investor Brand Network
Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies
August 17, 2023
Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights...
Via
Newsfile
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 7/24
July 24, 2023
Via
Investor Brand Network
Marker Therapeutics Inc. (NASDAQ: MRKR) Leading the Way in Friday Trading Based on Percentage Gain
June 09, 2023
Via
Investor Brand Network
Marker Therapeutics (NASDAQ: MRKR) Announces Leadership Transition and Strategic Partnership with CellReady to Strengthen Financial Position Through 2025
May 01, 2023
Houston-based Marker Therapeutics, Inc. (Nasdaq: MRKR) operates as a clinical-stage company focused on developing advanced T cell-based immunotherapies for hematological
Via
Spotlight Growth
Why Legend Biotech Stock Is Having Its Best Month Yet
April 25, 2023
With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high.
Via
MarketBeat
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
May 20, 2021
Via
FinancialNewsMedia
Topics
Death
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
